Study of the anti-MRSA activity of Rhizoma coptidis by chemical fingerprinting and broth microdilution methods.
暂无分享,去创建一个
[1] Xiaohe Xiao,et al. Multicomponent Therapeutics of Berberine Alkaloids , 2013, Evidence-based complementary and alternative medicine : eCAM.
[2] H. Suleria,et al. In vitro comparative study of Bougainvillea spectabilis "stand" leaves and Bougainvillea variegata leaves in terms of phytochemicals and antimicrobial activity , 2012 .
[3] M. Fujisawa,et al. Risk factors for anti-MRSA drug resistance. , 2012, International journal of antimicrobial agents.
[4] F. Lowy,et al. Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). , 2012, International journal of antimicrobial agents.
[5] J. Garbarino,et al. In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE model methods. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[6] Pei-lan Ding,et al. Determination of protoberberine alkaloids in Rhizoma Coptidis by ERETIC ¹H NMR method. , 2011, Journal of pharmaceutical and biomedical analysis.
[7] N. Reiner,et al. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. , 2011, Journal of ethnopharmacology.
[8] A. Pantosti,et al. DNA microarray-based characterisation of Panton–Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy , 2011, European Journal of Clinical Microbiology & Infectious Diseases.
[9] Ewa M Czekanska,et al. Assessment of cell proliferation with resazurin-based fluorescent dye. , 2011, Methods in molecular biology.
[10] S. Mandal,et al. Synergistic anti-Staphylococcus aureus activity of amoxicillin in combination with Emblica officinalis and Nymphae odorata extracts. , 2010 .
[11] Won‐Kyo Jung,et al. Synergistic effects between aminoethyl-chitosans and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA). , 2010, Bioorganic & medicinal chemistry letters.
[12] Xiao-Jun Ma,et al. Calorimetric study of the effect of protoberberine alkaloids in Coptis chinensis Franch on Staphylococcus aureus growth , 2008 .
[13] Y. Zhao,et al. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). , 2008, Journal of ethnopharmacology.
[14] K. Stellrecht,et al. Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia. , 2008, The Journal of antimicrobial chemotherapy.
[15] C. Jin,et al. Microcalorimetric investigation of the effect of berberine alkaloids from Coptis chinensis Franch on Staphylococcus aureus growth , 2008 .
[16] C. Jin,et al. Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. , 2008, Journal of biochemical and biophysical methods.
[17] H. Goossens,et al. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project , 2008 .
[18] Hyun-Soo Shin,et al. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex , 2007, Journal of Clinical Virology.
[19] N. Lee,et al. Optimization of antibacterial activity by Gold-Thread (Coptidis Rhizoma Franch) against Streptococcus mutans using evolutionary operation-factorial design technique. , 2007, Journal of microbiology and biotechnology.
[20] P. Appelbaum. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). , 2007, International journal of antimicrobial agents.
[21] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[22] D. Lim,et al. Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. , 2007, Bioorganic & medicinal chemistry letters.
[23] Jin Cheng,et al. Investigation of the effect of berberines alkaloids in Coptis chinensis Franch on Bacillus shigae growthby microcalorimetry , 2007 .
[24] A. Friedrich,et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[25] J. Boyce,et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.
[26] L. Maes,et al. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. , 2006, Journal of ethnopharmacology.
[27] M. Inoue,et al. Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus: a high initial inoculum of 1 x 108 cfu/ml for in vivo test. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] Zeng Chen. Advances in Pharmacological Studies of Coptis Chinesis , 2006 .
[29] Clinical,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .
[30] D. Sahm,et al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States , 2006, Annals of Clinical Microbiology and Antimicrobials.
[31] H. Goossens,et al. Evaluation of New Broth Media for Microdilution Antibiotic Susceptibility Testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria , 2005, Applied and Environmental Microbiology.
[32] Bo-chu Wang,et al. The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. , 2005, Colloids and surfaces. B, Biointerfaces.
[33] Roger Finch,et al. Lack of development of new antimicrobial drugs: a potential serious threat to public health. , 2005, The Lancet. Infectious diseases.
[34] K. Morikawa,et al. Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model. , 2005, International journal of antimicrobial agents.
[35] K. Tsujimoto,et al. Synergistic effects of anacardic acids and methicillin against methicillin resistant Staphylococcus aureus. , 2004, Bioorganic & medicinal chemistry.
[36] Fred C Tenover,et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. , 2003, The New England journal of medicine.
[37] A R Walmsley,et al. The structure and function of drug pumps. , 2001, Trends in microbiology.
[38] K. Lewis,et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Zervos,et al. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. , 2000, Diagnostic microbiology and infectious disease.
[40] K. Lewis,et al. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] H. Narita,et al. Quinolone susceptibility of norA-disrupted Staphylococcus aureus , 1997, Antimicrobial agents and chemotherapy.
[42] K. Murakami,et al. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus , 1987, Antimicrobial Agents and Chemotherapy.